Phase 2 Study of ADXS11-001 in Subjects With Carcinoma of the Anorectal Canal
Status:
Completed
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
This is a single arm Phase 2 study. Stage 1 and 2 of the study are monotherapy evaluations of
ADXS11-001 in 31 and 24 subjects, respectively with persistent/recurrent, loco-regional or
metastatic SCCA of the anorectal canal that have received at least 1 regimen for the
treatment of advanced disease